绩优基金规模大增，热门板块最新研判出炉

Group 1 - Multiple fund companies, including China Europe Fund and Everwin Fund, have reported significant growth in their performance funds in the third quarter, particularly in the technology and pharmaceutical sectors [1][2][3] - China Europe Fund's "China Digital Economy Mixed Fund" saw its scale increase from 1.527 billion to 13.022 billion, a growth of over 750%, with a year-to-date return exceeding 127% [2] - Everwin Technology Select Fund expanded from 1.166 billion to 11.521 billion, achieving a year-to-date return of over 185% [2] Group 2 - The Long城 Pharmaceutical Industry Select Fund reported an increase in scale from 1.132 billion to 1.790 billion, with a year-to-date return exceeding 80% [3] - The top holdings of Long城 Pharmaceutical Industry Select include companies like Innovent Biologics and 3SBio, focusing on clinical data and overseas licensing [3][5] - The AI sector is experiencing both investment opportunities and risks, with high valuations leading to increased volatility, suggesting a need for diversified investment strategies [4] Group 3 - The global cloud computing industry remains a key focus, with AI model values increasing and significant growth in computational power investments [4][5] - Fund managers are emphasizing the importance of balancing core pipeline competitiveness and the certainty of drug commercialization in the innovative drug sector [5]